Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Gross Profit 2009–2025
Harvard Bioscience, Inc. annual/quarterly gross profit history and growth rate from 2009 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Harvard Bioscience, Inc. gross profit for the quarter ending March 31, 2026 was 12.2 M, a 0.49% increase year-over-year.
- Harvard Bioscience, Inc. gross profit for the twelve months ending March 31, 2026 was 48.0 M, a 13.52% decrease year-over-year.
- Harvard Bioscience, Inc. annual gross profit for 2025 was 49.9 M, a 8.87% decrease from 2024.
- Harvard Bioscience, Inc. annual gross profit for 2024 was 54.8 M, a 17.11% decrease from 2023.
- Harvard Bioscience, Inc. annual gross profit for 2023 was 66.1 M, a 8.64% increase from 2022.
- Harvard Bioscience, Inc. annual gross profit for 2022 was 60.8 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Harvard Bioscience, Inc. Gross Profit — FAQ
Harvard Bioscience, Inc. (HBIO) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Harvard Bioscience, Inc.'s gross profit?
Harvard Bioscience, Inc. (HBIO) reported gross profit of $50M for fiscal 2025.
Where can I see HBIO's gross profit history?
The chart and table above show Harvard Bioscience, Inc.'s gross profit by year and by quarter, including the growth rate.